Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

Bugatti S.;De Stefano L.;Balduzzi S.;Luvaro T.;Cassaniti I.;Bogliolo L.;Mazzucchelli I.;D'Onofrio B.;Di Lernia M.;Mauric E.;Baldanti F.;Manzo A.;Montecucco C.
2021-01-01

2021
Immunology incorporates cellular and molecular studies in immunology, as well as clinical research in immunopathology, infectious disease, autoimmunity, and allergy. Host-pathogen interactions in infectious disease, as well as experimental therapeutic applications of immunomodulating agents are also considered. Resources dealing primarily with the biology of microbial, viral, or parasitic pathogens are excluded and are covered in the Microbiology category.
Esperti anonimi
Inglese
Internazionale
ELETTRONICO
80
12
1635
1638
4
biological therapy; COVID-19; glucocorticoids; methotrexate; vaccination
no
15
info:eu-repo/semantics/article
262
Bugatti, S.; De Stefano, L.; Balduzzi, S.; Greco, M. I.; Luvaro, T.; Cassaniti, I.; Bogliolo, L.; Mazzucchelli, I.; D'Onofrio, B.; Di Lernia, M.; Maur...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1439034
Citazioni
  • ???jsp.display-item.citation.pmc??? 31
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 41
social impact